The spread of a validated molecular marker of artemisinin partial resistance pfkelch13 R622I and association with pfhrp2/3 deletions in Eritrea
Selam Mihreteab, Karen Anderson, Irene Molina - de la Fuente, View ORCID ProfileColin J. Sutherland, David Smith, Jane Cunningham, View ORCID ProfileKhalid B Beshir, Qin Cheng
doi: https://doi.org/10.1101/2023.10.20.23297302
Selam Mihreteab
1National Malaria Control Program, Ministry of Health, Asmara, Eritrea
Karen Anderson
2Drug Resistance and Diagnostics, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia
3QIMR-Berghofer Medical Research Institute, Brisbane, Australia
Irene Molina - de la Fuente
4Carlos III Institute of Health, Madrid, Spain
5University of Alcala, Madrid, Spain
Colin J. Sutherland
6Faculty of Infectious Diseases, London School of Hygiene & Tropical Medicine, UK
David Smith
2Drug Resistance and Diagnostics, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia
3QIMR-Berghofer Medical Research Institute, Brisbane, Australia
Jane Cunningham
7Global Malaria Programme, World Health Organization, Geneva, Switzerland
Khalid B Beshir
6Faculty of Infectious Diseases, London School of Hygiene & Tropical Medicine, UK
Qin Cheng
2Drug Resistance and Diagnostics, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia
3QIMR-Berghofer Medical Research Institute, Brisbane, Australia
Article usage
Posted October 21, 2023.
The spread of a validated molecular marker of artemisinin partial resistance pfkelch13 R622I and association with pfhrp2/3 deletions in Eritrea
Selam Mihreteab, Karen Anderson, Irene Molina - de la Fuente, Colin J. Sutherland, David Smith, Jane Cunningham, Khalid B Beshir, Qin Cheng
medRxiv 2023.10.20.23297302; doi: https://doi.org/10.1101/2023.10.20.23297302
The spread of a validated molecular marker of artemisinin partial resistance pfkelch13 R622I and association with pfhrp2/3 deletions in Eritrea
Selam Mihreteab, Karen Anderson, Irene Molina - de la Fuente, Colin J. Sutherland, David Smith, Jane Cunningham, Khalid B Beshir, Qin Cheng
medRxiv 2023.10.20.23297302; doi: https://doi.org/10.1101/2023.10.20.23297302
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (660)
- Anesthesia (177)
- Cardiovascular Medicine (2578)
- Dermatology (218)
- Emergency Medicine (390)
- Epidemiology (12103)
- Forensic Medicine (10)
- Gastroenterology (749)
- Genetic and Genomic Medicine (4008)
- Geriatric Medicine (377)
- Health Economics (670)
- Health Informatics (2588)
- Health Policy (993)
- Hematology (357)
- HIV/AIDS (827)
- Medical Education (397)
- Medical Ethics (107)
- Nephrology (424)
- Neurology (3775)
- Nursing (207)
- Nutrition (560)
- Oncology (1967)
- Ophthalmology (574)
- Orthopedics (233)
- Otolaryngology (301)
- Pain Medicine (248)
- Palliative Medicine (72)
- Pathology (469)
- Pediatrics (1092)
- Primary Care Research (442)
- Public and Global Health (6447)
- Radiology and Imaging (1371)
- Respiratory Medicine (863)
- Rheumatology (394)
- Sports Medicine (336)
- Surgery (434)
- Toxicology (51)
- Transplantation (185)
- Urology (164)